| Literature DB >> 9433781 |
Y Takeuchi1, M Kitaomo, M R Chang, S Shirasaka, C Shimamura, Y Okuno, M Yamato, T Harayama.
Abstract
Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6-methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9433781 DOI: 10.1248/cpb.45.2096
Source DB: PubMed Journal: Chem Pharm Bull (Tokyo) ISSN: 0009-2363 Impact factor: 1.645